II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...
A vulnerable Alzheimer’s patient was deprived of her life savings after NHS officials “cut and pasted” details from other ...
Dozens of people traveled to Olympia to show support for SB 5337, which would require memory care certification for assisted ...
A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and ...
Students in the Pottsville Junior High School EAST Program are using their skills to help caregivers with loved ones who have dementia or Alzheimer's.
ScienceAlert on MSN1d
COVID-19 May Be Linked With Higher Alzheimer's Risk, Study FindsAside from the potential curse of long COVID, people who've had the SARS-CoV-2 virus may be more likely to develop high ...
Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...
1don MSN
A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...
Latin Times on MSN4d
Deceased Alzheimer Patient Was Denied Coverage After Wrong Patients' Test Results Were 'Cut and Paste' in Her AssessmentAn elderly Alzheimer's patient was denied coverage due to a botched assessment containing another patient's details, forcing her family to fight for six years to recover her life savings.
MALVERN, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies ...
Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback